[ Price : $8.95]
CDER announces a reorganization of the Office of Pharmaceutical Quality effective 1/14/2024.[ Price : $8.95]
FDA tells healthcare providers about labeling updates to Becton Dickinsons (BD) Phasix and GalaFlex mesh products that discourage ...[ Price : $8.95]
FDA approves a PMA for the Recor Medical Paradise renal denervation system to treat hypertension.[ Price : $8.95]
Becton Dickinsons CareFusion unit recalls its Alaris Patient Controlled Analgesia infusion pump module 8120 because the compatible...[ Price : $8.95]
A Lassman Law petition filed for an unidentified client asks FDA not to approve an Amryt NDA for Filsuvez to treat cutaneous manif...[ Price : $8.95]
Federal Register notice: FDA makes available a guidance entitled Compliance Policy for Cosmetic Product Facility Registration and ...[ Price : $8.95]
Former FDA reviewer Sarah McGarry joins consulting firm Greenleaf Health as senior vice president of drug and biological products.[ Price : $8.95]
The CDER Office of Prescription Drug Promotion says two Otsuka Rexulti ads contain misleading presentations of the drugs efficacy....